Fri, November 10, 2023

Farzin Haque Upgraded (VERA) to Strong Buy and Increased Target to $26 on, Nov 10th, 2023

Farzin Haque of Jefferies, Upgraded "Vera Therapeutics, Inc." (VERA) to Strong Buy and Increased Target from $18 to $26 on, Nov 10th, 2023.

Farzin has made no other calls on VERA in the last 4 months.



There are 3 other peers that have a rating on VERA. Out of the 3 peers that are also analyzing VERA, 1 agrees with Farzin's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $16 on, Friday, August 11th, 2023


These are the ratings of the 2 analyists that currently disagree with Farzin


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 26th, 2023
  • Vamil Divan of "Guggenheim" Initiated at Strong Buy and Held Target at $27 on, Wednesday, August 16th, 2023